Be Clinical, a science-led skincare brand has raised Rs 2 crore ($234,439) in a seed funding round led by Titan Capital, with additional backing from angel investor Aditya Agarwal.

The brand will utilise the capital to bring manufacturing in-house, improving operational workflows, and safeguarding the brand’s proprietary formulations.

Additionally, the brand plans to expand into new segments within the anti-ageing category.

Commenting on the funding, Hemangi Dhir, founder of Be Clinical in a statement said, “Securing this investment is a strong validation of our vision. Anti-ageing has often been treated as an afterthought, but at Be Clinical, it’s our primary focus. We’re building a brand that addresses a real and growing need.”

A spokesperson from Titan Capital added, “We invested in Be Clinical because it sits at the intersection of science and self-care. What truly stood out was the founder’s deep understanding of the modern skincare consumer—not just what they buy, but why.”

Founded by Hemangi Dhir, Be Clinical operates through a direct-to-consumer model across India.